Tuesday, December 16

Healthcare

Cigna to offer biosimilar to J&J’s arthritis drug Stelara at $0 out-of-pocket

09/06/20241 Min Read

arthritis biosimilar Cigna drug JampJs offer outofpocket Stelara

Previous ArticleEli Lilly bets $409M for AI-focused drug discovery (NYSE:LLY)

Next Article Perspective gets FDA fast track status for radiopharmaceutical VMT01